Bethany Petrey, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 5141 Rockbridge Rd, Shelbyville, KY 40065 Phone: 502-220-9476 |
News Archive
Takeda Canada, Inc. is pleased to announce that ULORICĀ® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Genes do not exist in isolation. Like beads on a string, they sit next to each other on long DNA molecules called chromosomes.
Janssen R&D Ireland announces that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of hepatitis C at The International Liver Congress 2013 of the European Association for the Study of the Liver, which will take place April 24 to 28 in Amsterdam, The Netherlands.
SmartTots announces Lena Sun, MD and Jeffrey William Sall, PhD, MD as the recipients of its 2013/2014 round of pediatric anesthesia research grants. The research grants are intended to support investigations into the existence of a clinical signal suggesting poor neurocognitive outcomes as the result of early exposure to anesthesia.
› Verified 5 days ago